跳至主要内容
临床试验/CTRI/2020/04/024430
CTRI/2020/04/024430尚未招募2 期

Role Of Kutajashtakleha In The Management Of Asrigdara With Special Reference To Abnormal Uterine Bleeding; A PROOF OF CONCEPT STUDY.

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients complaining of Asrigrdara any two of the following
  • Heavy Menstrual Bleeding ( Amount more than 80 ml ) or
  • Prolonged Menstrual Bleeding(with the duration of bleeding more
  • than 7 days )
  • Inter Menstrual Bleeding Or
  • Frequent Menstrual Cycle ( Interval Less Than 21 Days)
  • Patient Of Age Group 18 To 45 Years.

排除标准

  • Patients Having Bleeding Due To Abortion And Childbirth.
  • Patients Having Coagulation Disorders.
  • Any Type Of Malignancy.
  • Patients Having Sexually Transmitted Diseases( STDs )
  • Patients Having Any Severe Systemic Diseases.
  • Uterine And Pelvic Pathology Like- Polyps, Endometrial
  • Tuberculosis, Fibroid, Adenomyosis, Pelvic Inflammatory
  • Diseases etc.
  • Patients Using Intrauterine Contraceptive Devices( IUCDs).

研究者

相似试验